P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial
| Autor: | Canino, F., Barbolini, M., De Giorgi, U., Dominici, M., Gianni, L., Moscetti, L., Omarini, C., Zamagni, C., Molinaro, A., Antonelli, G., Baglio, F., Martinelli, G., Natalizio, S., Ponzoni, O., Piacentini, F. |
|---|---|
| Zdroj: | In The Breast April 2023 68 Supplement:S60-S60 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect